pyrimidin
annul
deriv
exhibit
signific
biolog
activ
versatil
object
chemic
modif
class
heterocycl
compound
repres
great
number
medicin
sed
barbitur
antivir
idoxuridin
tenofovir
penciclovir
antimetabolit
raltitrex
diuret
triamteren
howev
despit
decad
worth
search
bioactiv
agent
among
compound
pyrimidin
moieti
potenti
still
exhaust
progress
highthroughput
biolog
screen
technolog
great
varieti
heterocycl
deriv
provid
almost
unlimit
potenti
creat
physiolog
activ
molecul
thu
determin
need
develop
new
effect
method
synthesi
first
investig
thiopyrimidin
began
xix
howev
introduct
thiol
group
may
consid
less
known
direct
chemic
modif
provid
addit
opportun
function
abil
influenc
oxid
process
organ
therefor
present
review
devot
collect
analysi
literatur
data
regard
method
synthesi
studi
biolog
properti
pyrimidin
deriv
condens
analog
exocycl
sulfur
atom
posit
pyrimidin
ring
mani
case
method
synthesi
heterocycl
system
limit
direct
interact
variou
deriv
sulfurcontain
howev
method
format
condens
analog
base
heterocycl
reaction
domino
reaction
topic
present
review
heterocycl
although
format
system
use
heterocycl
process
less
explor
publish
exampl
literatur
thu
group
investig
interact
ethoxymethyliden
malononitril
methyl
ncycloalkylylidenecarbamohydrazonothio
led
format
spirocondens
heterocycl
system
contain
pyrimidin
ring
scheme
use
heterocycl
form
fluorinecontain
compound
thiopyrimidin
fragment
chlorid
ethylcarbamimidothio
use
start
compound
scheme
condens
follow
cycliz
intermedi
led
format
ethylsulfanyl
one
abdalla
use
previous
known
method
condens
keton
thiourea
form
compound
contain
fragment
condens
steroid
moieti
scheme
heterocycl
method
synthesi
annul
deriv
via
cyclocondens
reaction
known
origin
time
case
base
interact
bi
methylsulfanyl
methyliden
amino
acet
isothiocyan
relat
compound
thu
sauter
ethyl
obtain
ethyl
bi
methylsulfanyl
methyliden
amino
acet
synthes
annul
pyrimidin
system
name
ethyl
methylsulfanyl
thieno
yl
acet
scheme
chowdhuri
publish
result
studi
use
similar
approach
pyrimidin
deriv
format
author
use
electrophil
reagent
variou
oamino
nitril
oamino
ester
scheme
case
appropri
condens
pyrimidin
deriv
obtain
note
interact
peculiar
involv
acet
chain
cycliz
lead
isol
imidazo
one
reaction
product
weinstock
et
investig
product
thermal
cycliz
isothiocyan
form
via
interact
compound
potassium
thiocyan
shown
heat
compound
diphenyl
oxid
lead
format
trifluoromethyl
one
scheme
heterocycl
method
construct
base
heterocycl
process
widespread
first
inform
use
method
synthesi
compound
thioxopyrimidin
fragment
appear
patent
publish
claim
method
prepar
chemic
modif
substitut
condens
anilin
carbon
disulfid
scheme
similar
approach
use
synthesi
reaction
appropri
diamin
carbon
disulfid
scheme
cycliz
method
also
use
synthesi
pyrazolo
thion
anilin
deriv
scheme
reaction
proceed
quantit
compound
alkyl
methyl
iodid
correspond
smethyl
deriv
util
reaction
amin
synthes
pyrazolo
investig
yip
devot
synthesi
fluoresc
analog
adenosin
h
use
start
materi
interact
carbon
disulfid
pyridin
medium
form
compound
scheme
alkyl
oxid
compound
lead
nucleosid
respect
tautomer
discuss
proven
compar
analysi
uv
spectra
compound
product
alkyl
solut
variou
ph
work
publish
could
consid
develop
chemistri
consid
dedic
synthesi
scheme
nglycosid
h
use
start
compound
compound
display
fluoresc
emiss
maximum
nm
interact
substitut
anilin
carbon
disulfid
pyridin
lead
format
correspond
scheme
shishoo
et
investig
reactiv
toward
carbon
disulfid
alkalin
alcohol
solut
product
assign
structur
thieno
triazolo
thion
scheme
ir
mass
spectra
nmr
method
use
establish
structur
obtain
compound
thu
assumpt
exist
compound
thiol
form
debat
within
studi
compound
alkyl
dimethyl
sulfat
yield
methylsulfanyl
deriv
method
transform
adenosin
diphosph
adp
thioderiv
scheme
describ
first
stage
synthesi
interact
adp
chloroacetaldehyd
led
format
imidazo
purin
deriv
subsequ
alkalin
hydrolysi
compound
allow
obtain
transform
ribosylpyrophosph
n
diphosph
via
heterocycl
carbon
disulfid
alkyl
compound
yield
correspond
sulfanyl
n
diphosph
degrad
imidazol
cycl
nbromosuccinimid
allow
obtain
sulfanyl
adenosin
diphosph
synthesi
ethyl
use
synthesi
condens
deriv
describ
work
danswan
et
thu
shown
interact
compound
ethyl
isothiocyan
yield
one
scheme
alkyl
latter
methyl
iodid
subsequ
alcoholysi
obtain
methylsulfanyl
deriv
sodium
methoxid
lead
one
origin
method
access
triazolo
pyrimido
benzimidazol
system
includ
stage
format
modif
partial
hydrogen
fragment
present
work
cherkaoui
et
al
scheme
first
step
synthesi
interact
carbon
disulfid
basic
medium
result
imidazo
thion
convert
smethyl
deriv
reflux
compound
acet
benzoic
acid
hydrazid
led
mixtur
tetracycl
compound
n
aceto
benzo
hydrazid
interest
transform
publish
gewald
explor
reaction
substitut
deriv
phenyl
isocyan
scheme
establish
unlik
previous
describ
similar
case
cf
scheme
reaction
stop
nucleophil
addit
subsequ
cycliz
moieti
intermedi
format
pyrrolo
pyrimidin
proceed
tandem
nucleophil
addit
nucleophil
substitut
follow
format
thiopyrimidin
iminopyrimidin
cycl
note
structur
product
proven
complex
physicochem
method
nmr
ir
spectra
altern
synthesi
thiophosgen
reagent
sondhi
et
perform
reaction
aromat
heteroaromat
aliphat
diamin
aim
find
compound
analges
antiinflammatori
activ
shown
structur
product
greatli
depend
type
diamin
use
scheme
interact
compound
proceed
tandem
reaction
result
format
pyrimidin
imidazol
cycl
author
cite
studi
demonstr
reaction
proce
regioselect
manner
led
format
thion
replac
led
format
isol
pyrimidin
cycl
compound
low
yield
fact
could
explain
decreas
amino
group
nucleophil
due
electron
effect
pyridin
nitrogen
atom
interact
yield
bispyrimidin
deriv
anoth
good
exampl
heterocycl
process
involv
carbon
disulfid
demonstr
et
synthesi
scheme
modif
allow
obtain
compound
signific
antimicrobi
activ
part
studi
aim
creat
new
antiulc
drug
similar
method
start
benzimidazol
deriv
develop
synthesi
thion
product
salkyl
scheme
format
heterocycl
reaction
multifunct
compound
contain
isothiocyan
carbonyl
group
systemat
found
reaction
isothiocyan
contain
aldehyd
compound
keton
compound
carbonyl
group
hydrochlorid
led
format
three
altern
product
scheme
depend
reaction
condit
structur
carbonyl
compon
reaction
compound
also
describ
paper
scheme
thu
thion
form
use
isothiocyan
reflux
start
compound
methanol
turn
conduct
reaction
compound
ambient
temperatur
increas
durat
ten
day
result
format
oxazolo
farghali
publish
work
describ
heterocycl
interact
carbon
disulfid
form
pyrazolo
scheme
anoth
good
exampl
use
heterocycl
assembl
report
shown
interact
carbon
disulfid
pyridin
led
pyrido
thieno
thion
scheme
kovalenko
et
publish
seri
paper
devot
develop
prepar
method
studi
antibacteri
anticanc
activ
potassium
triazino
salkyl
deriv
scheme
heterocycl
appropri
one
carbon
disulfid
ethyl
xanthogen
use
form
target
tricycl
system
introduct
microwaveassist
organ
synthesi
technolog
affect
also
area
review
anilin
soukri
et
synthes
benzimidazo
scheme
irradi
mixtur
absorb
graphit
consist
alkyl
product
excess
anthranil
acid
deriv
led
new
heterocycl
system
quinazolino
antypenko
et
show
high
potenti
anilin
start
compound
heterocycl
thu
interact
compound
carbon
disulfid
potassium
hydroxid
ethanol
potassium
ethyl
xanthogen
isopropanol
led
format
potassium
tetrazolo
scheme
furthermor
thiolat
thion
util
alkyl
reaction
variou
reagent
haloalkan
haloalkylamin
halo
keton
halocarboxyl
acid
amid
obtain
ssubstitut
deriv
phenylamin
also
act
heterocycl
carbon
disulfid
presenc
potassium
hydroxid
ethanol
potassium
ethyl
xanthogen
possibl
pathway
reaction
discuss
potassium
triazolo
respect
thion
identifi
product
reaction
subsequ
compound
use
synthesi
ssubstitut
deriv
besid
author
conduct
singlecryst
xray
analysi
one
basic
structur
indisput
determin
cycliz
direct
tandem
cycliz
tandem
reaction
alreadi
present
previou
section
due
fact
describ
within
scope
cyclocondens
present
section
interest
dominoprocess
consid
one
domino
reaction
develop
sauter
et
interact
ethyl
led
format
condens
pyrimidin
imidazol
fragment
form
part
thiopyrano
thieno
one
molecul
scheme
reaction
nitril
ethyl
bi
methylsulfanyl
methyliden
amino
acet
proceed
similar
way
form
thiopyrano
thieno
one
latter
also
obtain
direct
alkyl
compound
methyl
iodid
interact
describ
bodtk
result
research
show
studi
reaction
yield
imidazo
thion
scheme
format
altern
product
dimroth
rearrang
imidazo
thion
disproven
noesi
experi
xray
diffract
analysi
synthesi
transform
thion
describ
hull
part
seri
work
devot
studi
interact
thiophosgen
heterocycl
compound
oisothiocyanatotranscinnam
aldehyd
obtain
cleavag
quinolin
cycl
compound
thiophosgen
basic
medium
scheme
interact
aldehyd
hydrazin
hydrat
ethanol
led
format
tricycl
compound
latter
reduc
sodium
borohydrid
correspond
tetrahydro
deriv
use
start
compound
format
besid
possibl
alkyl
nucleophil
cleavag
compound
shown
obtain
compound
respect
origin
method
construct
mercaptopyrimidin
fragment
offer
shown
substitut
alkyl
nmethylidenecarbamohydrazonothio
readili
interact
ethoxymethylen
malononitril
form
triazolo
scheme
product
nucleophil
substitut
propos
intermedi
reaction
use
perchlor
synthesi
heterocycl
system
describ
work
zvezdina
et
thiosemicarbazidemedi
pyran
ring
open
compound
led
thion
obtain
togeth
pyridin
deriv
scheme
alkyl
thion
methyl
iodid
provid
new
smethyl
deriv
possibl
tautomer
transform
compound
studi
uv
spectrometri
method
franci
et
studi
synthesi
chemic
modif
triazolo
quinazolin
thu
found
interact
carbohydrazid
led
format
triazolo
thion
scheme
methyl
compound
led
methylsulfanyl
deriv
sme
group
molecul
compound
underw
substitut
ammonia
yield
correspond
amin
kranz
et
publish
work
describ
synthesi
thion
via
condens
dehydroacet
acid
thiosemicarbazid
scheme
two
altern
pathway
transform
propos
consid
fact
reaction
propos
intermedi
diacetylaceton
thiosemicarbazid
also
yield
compound
pathway
b
accept
probabl
al
describ
synthesi
modif
latter
obtain
via
threecompon
condens
nphenylurea
ethyl
aromat
aldehyd
ethanol
scheme
compound
use
start
materi
synthesi
condens
heterocycl
system
contain
moieti
louvel
publish
result
work
aim
search
novel
nonglycosid
agonist
adenosin
receptor
hetarylmethyl
sulfanyl
select
target
compound
synthes
twostep
procedur
includ
onepot
threecompon
cyclocondens
aromat
aldehyd
thiourea
malonodinitril
follow
alkyl
obtain
scheme
pfeiffer
et
develop
approach
could
success
use
format
benzothieno
triazolo
thion
well
benzothieno
imidazo
thion
method
base
interact
hydrazid
aminocarbonyl
compound
allow
obtain
target
compound
high
yield
scheme
biolog
properti
condens
deriv
studi
biolog
activ
compound
contain
moieti
began
practic
time
systemat
develop
synthet
approach
toward
class
compound
one
first
refer
biolog
activ
found
discuss
along
method
synthesi
antiarthrit
activ
trifluoromethyl
one
work
jefferson
one
earli
studi
describ
purpos
synthesi
compound
abil
initi
platelet
aggreg
main
motiv
studi
presenc
activ
optim
molecul
led
synthesi
sulfanyl
n
diphosph
show
strong
abil
initi
platelet
aggreg
thu
ribosylpyrophosph
could
success
use
start
product
synthesi
deriv
adenosin
abil
initi
platelet
aggreg
report
strong
antifung
effect
compound
trichophyton
rubrum
chrysosporium
tropicum
along
moder
antimicrobi
activ
bacillu
cereu
antitumor
antimicrobi
fungicid
activ
ssubstitut
tetrazolo
thion
describ
antypenko
et
shown
tetrazolo
ethanon
fig
tetrazolo
quinazolin
inhibit
growth
candida
albican
compound
inhibit
growth
aureu
e
faecali
compound
reveal
moder
antitumor
activ
standard
nci
line
panel
fig
antitumor
antifung
activ
triazolo
thion
also
observ
biliy
et
thu
potassium
triazolo
b
exhibit
high
antibacteri
activ
aureu
mic
mbc
fig
import
note
potassium
triazolo
also
effect
methicillinresist
strain
aureu
ram
devot
search
leishmanicid
herbicid
among
pyrimidin
deriv
condens
analog
research
leishmanicid
activ
conduct
hamster
dose
mgkg
author
establish
among
investig
compound
ssubstitut
fig
show
highest
activ
herbicid
activ
synthes
compound
investig
echinochloa
crusgal
lactuca
sativa
plant
subfamili
lemnoidea
establish
synthes
compound
exhibit
strong
herbicid
activ
lactuca
sativa
plant
subfamili
lemnoidea
reason
activ
echinochloa
crusgal
within
work
dianova
et
toxic
anticanc
antivir
radioprotect
activ
triazolo
sulfanyl
acet
acid
deriv
fig
examin
breast
adenocarcinoma
sarcoma
cell
line
use
anticanc
test
abovement
acid
show
low
anticanc
effect
cell
sarcoma
growth
inhibit
low
stimul
effect
growth
breast
adenocarcinoma
wherea
amid
inhibit
growth
sarcoma
carcinoma
growth
inhibit
hydrazid
inhibit
cell
growth
slightli
stimul
growth
sarcoma
hydrazon
unexpectedli
exhibit
growthstimul
effect
cell
sarcoma
none
studi
compound
show
activ
cell
sarcoma
investig
antivir
activ
synthes
compound
refer
studi
reveal
acid
exhibit
pronounc
antivir
activ
influenza
virus
type
b
index
protect
type
type
b
chern
describ
antihypertens
effect
abil
act
select
adrenoreceptor
ar
antagonist
seri
quinazolin
deriv
fig
especi
compound
contain
thiopyrimidin
moieti
studi
conduct
rat
hypertens
use
prazosin
refer
drug
result
show
test
compound
reduc
blood
pressur
h
h
administr
work
sondhi
antivir
activ
hiv
viru
studi
among
pyrimido
benzimidazol
deriv
unfortun
result
studi
show
low
activ
compound
research
also
investig
antiinflammatori
analges
antiameb
activ
compound
similar
describ
previou
work
shown
test
compound
fig
exhibit
antiinflammatori
effect
rang
dose
mgkg
among
compound
thion
show
moder
antiinflammatori
activ
compound
show
high
antiamoeb
activ
identifi
relat
biheterocycl
compound
possess
antiinflammatori
analges
effect
well
abil
inhibit
activ
protein
kinas
fig
anoth
group
report
antiinflammatori
anticanc
activ
fuse
pyrimidin
seri
result
show
compound
ssubstitut
analog
compound
fig
moder
antiinflammatori
activ
dose
mgkg
investig
anticanc
activ
show
compound
also
inhibit
cell
growth
melanoma
prostat
colon
breast
ovarian
cancer
cancer
cn
compound
nacyl
analog
compound
activ
inhibit
half
growth
cnc
cancer
cell
concentr
nalbandyan
conduct
studi
psychotrop
properti
pyrano
furo
triazolo
pyrimidin
pyrano
furo
tetrazolo
pyrimidin
fig
shown
compound
b
seri
exhibit
anxiolyt
antiamnest
atax
anticorazol
activ
li
report
aroyl
phenylacetyl
methyl
sulfanyl
n
triphosph
promis
nucleosidebas
revers
transcriptas
inhibitor
fig
bhuiyan
report
signific
antimicrobi
antifung
activ
imidazo
one
fig
lauria
et
present
search
anticanc
agent
among
thiopyrimidin
moietycontain
annul
pyrrolopyrimidin
fig
use
virtual
lockandkey
chemometr
protocol
present
data
antimicrobi
activ
pyrimido
quinolin
pyrimido
pyrimidin
moder
antimicrobi
activ
compound
fig
discuss
research
continu
search
antioxid
antiinflammatori
analges
agent
among
azopyrimidoquinolin
pyrimidoquinazolin
one
identifi
compound
highest
antioxid
activ
thu
abil
inhibit
oxid
process
compar
ascorb
acid
refer
drug
member
class
compound
also
activ
antiinflammatori
agent
carrageenaninduc
paw
edema
model
protect
percent
kovalenko
et
present
result
biolog
activ
studi
triazino
product
modif
accord
obtain
data
compound
wide
rang
biolog
effect
includ
anticanc
antiviri
antibacteri
antifung
antivir
properti
characterist
triazino
fig
dialkylaminoethyl
moieti
compound
inhibit
tacarib
viru
si
sar
coronaviru
si
venezuelan
equin
enceph
viru
si
influenza
viru
type
si
influenza
viru
type
si
influenza
viru
type
b
si
influenza
viru
type
si
also
shown
triazino
activ
follow
tumor
cell
line
sr
leukemia
cn
cancer
renal
cancer
nonsmal
lung
cancer
colo
colon
cancer
melanoma
ovarian
cancer
si
cn
cancer
si
melanoma
si
renal
cancer
si
prostat
cancer
si
breast
cancer
si
n
triazino
sulfanyl
acetamid
fig
identifi
lead
compound
remark
anticanc
signific
number
compound
test
anticanc
activ
allow
evalu
quantit
cowork
studi
anticanc
activ
condens
analog
obtain
data
allow
identifi
sever
compound
b
show
cytotox
activ
test
line
fig
compound
combin
steroid
fragment
studi
anabol
androgen
activ
well
acut
shown
compound
almost
nontox
abl
increas
muscl
mass
determin
role
moieti
respect
biolog
activ
note
suggest
presenc
pyrimidin
cycl
thiol
group
condit
format
hydrogen
bond
human
androgen
receptor
hgr
abdelhafez
describ
result
purpos
search
novel
anticanc
agent
among
compound
contain
benzofuran
cycl
includ
substanc
latter
combin
moieti
shown
thion
b
fig
possess
inhibit
activ
suppress
growth
cancer
cell
line
vitro
vivo
result
dock
studi
aim
find
bind
featur
synthes
compound
correl
dock
studi
score
inhibit
anticanc
activ
lung
carcinoma
nci
glioblastoma
prostat
cancer
work
devot
synthesi
evalu
antivir
antimicrobi
activ
complex
platinum
ruthenium
shown
among
obtain
compound
two
name
diazenyl
n
benzenesulfonamid
diazenyl
one
complex
pt
ii
reveal
signific
antivir
activ
fig
former
also
compound
activ
aureu
e
coli
quit
predict
consid
presenc
sulfamerazin
fragment
molecular
structur
present
result
identifi
ssubstitut
agonist
partial
agonist
adenosin
receptor
paper
author
discuss
kinet
bind
found
depend
natur
substitu
bind
period
may
vari
rang
min
also
shown
correl
kinet
paramet
complex
dissoci
effect
synthes
compound
adenosin
receptor
agonist
piechowicz
describ
inhibit
activ
compound
pyrimidin
thiazol
fragment
join
thioacetamid
linker
toward
cadepend
chlorid
channel
despit
fact
synthes
compound
inact
concentr
author
isol
molecul
may
identifi
lead
compound
fig
santhoshi
show
ssubstitut
deriv
b
fig
contain
fragment
possess
inhibit
activ
condens
analog
promis
class
bioactiv
agent
condens
deriv
especi
biolog
activ
compar
less
studi
nevertheless
also
captur
attent
medicin
chemist
among
possibl
synthet
pathway
heterocycl
wide
use
method
fragment
format
